Release Date: 21/04/22 09:45 Summary: Quarterly Activities/Appendix 4C Cash Flow Report Price Sensitive: Yes Download Document 441.52KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status